{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:12:39Z","timestamp":1790845959436,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014452","name":"College of Medicine, University of Cincinnati","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.resinv.2023.12.009","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:55:57Z","timestamp":1704848157000},"page":"216-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Safety and efficacy of sirolimus in hospitalised patients with COVID-19 pneumonia"],"prefix":"10.1016","volume":"62","author":[{"given":"Abhishek","family":"Singla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nusrat","family":"Harun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Dilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3023-5516","authenticated-orcid":false,"given":"Karim","family":"Merchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"McMahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Ingledue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina A.","family":"Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Korbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5429-2609","authenticated-orcid":false,"given":"Elizabeth J.","family":"Kopras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9112-1315","authenticated-orcid":false,"given":"Nishant","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2023.12.009_bib1","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.resinv.2023.12.009_bib2","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1080\/22221751.2020.1799723","article-title":"Dysregulation in Akt\/mTOR\/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells","volume":"9","author":"Appelberg","year":"2020","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.resinv.2023.12.009_bib3","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/s41467-021-22166-4","article-title":"SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition","volume":"12","author":"Mullen","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.resinv.2023.12.009_bib4","series-title":"Product information: rapamune (sirolimus)","year":"2021"},{"key":"10.1016\/j.resinv.2023.12.009_bib5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08155","article-title":"mTOR regulates memory CD8 T-cell differentiation","volume":"460","author":"Araki","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.resinv.2023.12.009_bib6","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1016\/S2666-7568(21)00062-3","article-title":"Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials","volume":"2","author":"Mannick","year":"2021","journal-title":"The Lancet Healthy Longevity"},{"key":"10.1016\/j.resinv.2023.12.009_bib7","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/TP.0000000000001777","article-title":"The role of mTOR inhibitors in the management of viral infections: a review of current literature","volume":"102","author":"Bowman","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.resinv.2023.12.009_bib8","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1128\/AAC.03659-14","article-title":"Antiviral potential of ERK\/MAPK and PI3K\/AKT\/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis","volume":"59","author":"Kindrachuk","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2023.12.009_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007428","article-title":"Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration","volume":"14","author":"Jia","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.resinv.2023.12.009_bib10","doi-asserted-by":"crossref","first-page":"E6613","DOI":"10.1073\/pnas.1621172114","article-title":"Mitogenic stimulation accelerates influenza-induced mortality by increasing susceptibility of alveolar type II cells to infection","volume":"114","author":"Nikolaidis","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.resinv.2023.12.009_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/CCM.0b013e3182a2727d","article-title":"Adjuvant treatment with a mammalian target of rapamycin inhibitor, sirolimus, and steroids improves outcomes in patients with severe H1N1 pneumonia and acute respiratory failure","volume":"42","author":"Wang","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.resinv.2023.12.009_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.3110","article-title":"Computational drug repurposing study of the RNA binding domain of SARS\u2010CoV\u20102 nucleocapsid protein with antiviral agents","volume":"37","author":"Tatar","year":"2021","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.resinv.2023.12.009_bib13","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1080\/07391102.2020.1839563","article-title":"Targeting SARS-CoV-2 nucleocapsid oligomerization: insights from molecular docking and molecular dynamics simulations","volume":"40","author":"Ahamad","year":"2022","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.resinv.2023.12.009_bib14","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1099\/jmm.0.001203","article-title":"Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2","volume":"69","author":"Pokhrel","year":"2020","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.resinv.2023.12.009_bib15","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2023.12.009_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108539","article-title":"mTORC inhibitor Sirolimus deprograms monocytes in \"cytokine storm\" in SARS-CoV2 secondary hemophagocytic lymphohistiocytosis- like syndrome","volume":"218","author":"Karsulovic","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.resinv.2023.12.009_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell discovery"},{"key":"10.1016\/j.resinv.2023.12.009_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102571","article-title":"Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies","volume":"19","author":"Fagone","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.resinv.2023.12.009_bib19","doi-asserted-by":"crossref","DOI":"10.2196\/21169","article-title":"The anatomy of the SARS-CoV-2 biomedical literature: introducing the CovidX network algorithm for drug repurposing recommendation","volume":"22","author":"Gates","year":"2020","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.resinv.2023.12.009_bib20","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1080\/07391102.2020.1824816","article-title":"Repurposing of the approved small molecule drugs in order to inhibit SARS-CoV-2 S protein and human ACE2 interaction through virtual screening approaches","volume":"40","author":"Kalhor","year":"2022","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.resinv.2023.12.009_bib21","article-title":"Machine learning and network medicine approaches for drug repositioning for COVID-19","volume":"3","author":"de Siqueira Santos","year":"2022","journal-title":"Patterns"},{"key":"10.1016\/j.resinv.2023.12.009_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-01410-3","article-title":"Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis","volume":"11","author":"MotieGhader","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2023.12.009_bib23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.resinv.2023.12.009_bib24","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41467-022-28639-4","article-title":"Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications","volume":"13","author":"Al-Nesf","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.resinv.2023.12.009_bib25","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.resinv.2023.12.009_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-14-41","article-title":"The statistical interpretation of pilot trials: should significance thresholds be reconsidered?","volume":"14","author":"Lee","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.resinv.2023.12.009_bib27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0360-3016(80)90153-4","article-title":"Statistical considerations for pilot studies","volume":"6","author":"Schoenfeld","year":"1980","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.resinv.2023.12.009_bib28","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/sim.4357","article-title":"Optimal sample sizes for phase II clinical trials and pilot studies","volume":"31","author":"Stallard","year":"2012","journal-title":"Stat Med"},{"key":"10.1016\/j.resinv.2023.12.009_bib29","first-page":"19","article-title":"Risk factors for severe COVID-19 outcomes among persons aged\u2265 18 years who completed a primary COVID-19 vaccination series\u2014465 health care facilities","volume":"vol. 71","author":"Yek","year":"2022"},{"key":"10.1016\/j.resinv.2023.12.009_bib30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","article-title":"Therapeutic strategies for COVID-19: progress and lessons learned","volume":"22","author":"Li","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.resinv.2023.12.009_bib31","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1001\/jamaoncol.2021.3585","article-title":"Association of antineoplastic therapy with decreased SARS-CoV-2 infection rates in patients with cancer","volume":"7","author":"Foote","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.resinv.2023.12.009_bib32","first-page":"1","article-title":"Evaluation of off-label rapamycin use to promote healthspan in 333 adults","author":"Kaeberlein","year":"2023","journal-title":"GeroScience"},{"key":"10.1016\/j.resinv.2023.12.009_bib33","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.chest.2020.11.005","article-title":"Incidence of vte and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis","volume":"159","author":"Jim\u00e9nez","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2023.12.009_bib34","article-title":"Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis","volume":"29","author":"Malas","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.resinv.2023.12.009_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s11658-022-00308-w","article-title":"The probable role and therapeutic potential of the PI3K\/AKT signaling pathway in SARS-CoV-2 induced coagulopathy","volume":"27","author":"Khezri","year":"2022","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.resinv.2023.12.009_bib36","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.chest.2021.12.640","article-title":"COVID-19 in lymphangioleiomyomatosis: an international study of outcomes and impact of mechanistic target of rapamycin inhibition","volume":"161","author":"Baldi","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2023.12.009_bib37","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1007\/s11427-022-2102-3","article-title":"Humoral response to inactivated SARS-CoV-2 vaccines in patients on sirolimus alone","volume":"65","author":"Cheng","year":"2022","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.resinv.2023.12.009_bib38","series-title":"Effects of sirolimus on anti-SARS-CoV2 vaccination in patients with LAM","author":"Worthy","year":"2023"},{"key":"10.1016\/j.resinv.2023.12.009_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.852973","article-title":"mTOR inhibitor use is associated with a favorable outcome of COVID-19 in patients of kidney transplant: results of a retrospective study","volume":"9","author":"Pinchera","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.resinv.2023.12.009_bib40","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of covid-19 - final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2023.12.009_bib41","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534524000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534524000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:33:49Z","timestamp":1761950029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534524000029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2212534524000029"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2023.12.009","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of sirolimus in hospitalised patients with COVID-19 pneumonia","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2023.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V. on behalf of The Japanese Respiratory Society.","name":"copyright","label":"Copyright"}]}}